Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
|Videos|August 9, 2017
How Specialty Pharmacists Can Prepare Patients to Switch to Biosimilars
Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.
Advertisement
Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
4
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
5